It was only a matter of time before Ekso Bionics Holdings Inc. (OTCBB: EKSO) stock broke into the Money Morning list of top performing stocks in 2015.
On the year, EKSO stock is up 53.7%. Money Morning Chief Investment Strategist Keith Fitz-Gerald said that EKSO stock is one of his favorite companies right now because it taps into a dynamic market trend.
That trend is human augmentation. Ekso creates exoskeletons - "Ekso suits" - to provide physical therapy and mobility to people with severe mobility disorders, stroke victims, and those who have experienced significant spinal trauma. Fitz-Gerald said they are "pioneering neural rehabilitation in ways that were the realm of science fiction until recently."
So where is Ekso stock headed? Currently trading at $2.09, Fitz-Gerald said he sees the company heading to $21.85 a share by 2020. That's a 945% gain in five years.
One thing for investors to note - Ekso is small, and volatile. But if you can handle the volatility, it's a solid "Buy."
"If you don't get into the stock now, you could lose the "first mover" advantage," Fitz-Gerald added.
To see where EKSO stock fits in among our 2015 top stocks to invest in, give the chart below a look.
Money Morning's Top 10 Stocks 2015
This past week, U.S. market indexes were mixed. As of yesterday (Thursday), the Dow was down 0.3% on the year, while the S&P 500 was up 0.4%. The Nasdaq, which took a beating the week before, inched up a bit for a year-to-date climb of 3.2%. This week's Money Morning 2015 stock picks feature an exciting new name in human augmentation, as well as a number of biotech stocks.
Here are our top 10 for year-to-date gains as of the April 2 close:
Name | Symbol | 2015 Gain % |
Prothena Corp. Plc | PRTA | 84.4% |
Lannett Co. Inc. | LCI | 54.8% |
Ekso Bionics Holdings Inc. | EKSO | 53.7% |
Ambarella Inc. | AMBA | 45.9% |
U.S. Silica Holdings Inc. | SLCA | 38.9% |
Novavax Inc. | NVAX | 33.9% |
Boston Scientific Corp. | BSX | 33.7% |
Skyworks Solutions Inc. | SWKS | 32.7% |
Alon USA Energy Inc. | ALJ | 31.7% |
Thoratec Corp. | THOR | 28.7% |
Sources: Google Finance, Money Morning Staff Research